Research on improving treatments for childhood leukemia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the genomics and drug sensitivity of childhood leukemia to enhance precision medicine approaches. It consists of two main projects: the first focuses on sequencing genetic material from children with various types of leukemia to identify potential targeted therapies, while the second aims to develop novel antibodies for treating high-risk cases using animal models. The goal is to tailor treatments based on individual patient profiles and improve outcomes for those with relapsed or refractory leukemia.

Why it matters

Who can join: the full rules

List of inclusion criteria:

1. acute lymphoblastic leukemia (ALL) or
2. acute myeloid leukemia (AML) or

3 .mixed phenotype acute leukemia (MPAL) or

4\. juvenile myelomonocytic leukemia (JMML) or

5\. myelodysplastic syndromes (MDS) or

6\. normal bone marrow donor

List of exclusion criteria:

1. This study will not recruit subjects who are unable to understand English or Chinese.
2. Patient or parent refusal

Where it's running

• Hong Kong Children Hospital
  Hong Kong, Hksar, China Recruiting

Study contacts

• Principal investigator: Kam Tong Leung, Ph. D. — Chinese University of Hong Kong
• Study coordinator: Kathy Chan, Ph. D.
• Email: kathyyychan@cuhk.edu.hk
• Phone: 852-35052858

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Precision medicine for children with cancer

  This study is testing if personalized medicine can improve treatment and outcomes for children with different types of cancer in Australia and New Zealand.

  Recruiting at 10 sites Australian & New Zealand Children's Haematology/Oncology Group · Adelaide and 10 other locations · NCT05504772

• Postpartum exercise to improve heart and metabolic health in women at high risk for preeclampsia

  This pilot study tests whether a 12‑week postpartum exercise program can improve heart health and metabolic markers in women who were at high risk for preeclampsia.

  Recruiting Chinese University of Hong Kong · Hong Kong, Hong Kong · NCT07921173

• Ultrasound-guided microwave ablation for benign thyroid nodules

  This study tests whether using ultrasound-guided microwave ablation to shrink benign thyroid nodules under local anesthesia is safe and effective, compared with traditional surgery.

  Recruiting Chinese University of Hong Kong · Shatin · NCT07906821

• Romiplostim added to standard ESA therapy in adults on hemodialysis with ESA-resistant anemia

  This phase 2 study tests whether adding romiplostim to ongoing ESA treatment is safe and tolerable for adults on dialysis whose anemia does not respond well to ESAs.

  Recruiting Phase 2 Chinese University of Hong Kong · Hong Kong · NCT07854561

• Metomidate PET-CT vs Usual Care for Primary Aldosteronism

  This study tests whether [11C] metomidate PET-CT can help orient treatment for people with primary aldosteronism compared with the usual adrenal venous sampling approach.

  Recruiting Chinese University of Hong Kong · Shatin · NCT07814105

• VR-based sensory stimulation to prevent delirium in ICU patients

  This trial tests whether immersive virtual reality sensory stimulation can delay or reduce delirium in adult ICU patients compared with a non-immersive, tablet-based sensory experience.

  Recruiting Chinese University of Hong Kong · Shenzhen, Guangdong · NCT07806422

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.